-+ 0.00%
-+ 0.00%
-+ 0.00%
Teva announces Q3 2026 aide memoire availability
Share
Listen to the news
Teva announces Q3 2026 aide memoire availability
  • Teva posted its fiscal Q3 2026 Aide Memoire for investors ahead of results due Nov. 3, 2026 at 7:00 a.m. ET.
  • A conference call is scheduled for 8:00 a.m. ET the same day.
  • Q3 2026 Aide Memoire


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva Pharmaceutical Industries Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609231645PRIMZONEFULLFEED1001274300) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending